Insider Trading & Ownership of Scott Dunseth Myers

Location: San Diego, CA
Summary: The estimated net worth of Scott Dunseth Myers is at least $6,329,688 dollars as of 25 Aug 2025. Scott Dunseth Myers is the Chief Executive Officer, Director of Viridian Therapeutics, Inc.\DE and owns shares of Viridian Therapeutics, Inc.\DE (VRDN) stock worth about $5.45M. Scott Dunseth Myers is the Director of Zentalis Pharmaceuticals, Inc. and owns shares of Zentalis Pharmaceuticals, Inc. (ZNTL) stock worth about $437K. Scott Dunseth Myers is the Director of DYNAVAX TECHNOLOGIES CORP and owns shares of DYNAVAX TECHNOLOGIES CORP (DVAX) stock worth about $378.7K. Scott Dunseth Myers is the Director of Harpoon Therapeutics, Inc. and owns shares of Harpoon Therapeutics, Inc. stock worth about $64.4K.
Signature: Scott Myers, by /s/ Trevor Dutcher, Attorney-in-Fact
All Insider Reports: All Insider Reports

Notify me when Scott Dunseth Myers files a new Insider Trading report.

Ownership of Scott Dunseth Myers

Symbol	Company	Relationship	Holdings Value	Past Year Net Change	Change %	Report Period
VRDN	Viridian Therapeutics, Inc.\DE	Chief Executive Officer, Director	$5,449,500			12 Apr 2023
ZNTL	Zentalis Pharmaceuticals, Inc.	Director	$437,045	+$29,373	+7.2%	17 Jun 2025
DVAX	DYNAVAX TECHNOLOGIES CORP	Director	$378,743	+$41,116	+12%	22 Aug 2025
HARP	Harpoon Therapeutics, Inc.	Director	$64,400			11 Mar 2024
RNAC	Cartesian Therapeutics, Inc.	Director				13 Nov 2023
TRIL	Trillium Therapeutics Inc.	Director				17 Nov 2021

Sym	Company	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.